Unscheduled bleeding on HRT 

• This session will look at the recommendations from the new BMS guideline and consider cases which illustrate the practical application of this guidance.

Dementia – is HRT the answer?

• According to Dementia UK, the risk of a person over age 65 developing Alzheimer’s disease or vascular dementia doubles every 5 years. Twice as many women over age 65 are diagnosed with Alzheimer’s than men, implying that hormones may play a part. If the incidence of Alzheimer’s increases post menopause, is there a role for HRT in prevention? What about the effect of different types or routes of delivery of HRT? This session will review the current data and provide take home messages to consider in discussion with patients.

Measuring estradiol serum levels

• There is no current guidance on measuring estradiol levels and confusion exists as to what is normal.  This session will look at how estrogens are metabolised, what expected serum levels may be and how they can significantly fluctuate physiologically, in the perimenopause and with different forms of HRT.

The Menopause Masterclass carries 3 CPD credits.

Delegates will be signposted to supporting material for the webinar once registered. During the live interactive webinar panel session on Thursday 14 November delegates will have plenty of opportunity to ask questions. All delegates will receive a copy of the presentations after the event.

Please note this webinar will not be recorded.

£50 for members*, £75 for non members

We are unable to issue refunds for this event.

*Membership discount only applicable with 2024 membership